Publications by authors named "Penny Moore"

Claim this Profile
G
Glycan-reactive antibodies isolated from human HIV-1 vaccine trial participants show broad pathogen cross-reactivity.
Parker J Jamieson, Xiaoying Shen, Alexandra A Abu-Shmais, Perry T Wasdin, Katarzyna Janowska, Penny L Moore

J Virol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transplacental transferred anti-SARS-CoV-2 neutralizing antibodies in unvaccinated pregnant women in Cameroon occurred during the COVID-19 pandemic, but not in the pre-pandemic period.
Reine Medouen Ndeumou Seumko'o, Thandeka Moyo-Gwete, Tandile Hermanus, Sosthene Hillary Matabou Tene, Romeo Brice Dieffouo Djounda, Penny L Moore

Front Immunol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of DNA omicron booster Alveavax-v1.2 in Ad26.COV2.S-vaccinated adults.
Maximilian Schons, Tobias Odendahl, James A Smith, Kyle Fish, Anemone Franz, Penny Moore

iScience· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retaining African networks is urgent for global health.
Jinal N Bhiman, Jennifer Serwanga, Chinedu A Ugwu, Ines Vigan-Womas, Peter K Quashie, Penny L Moore

Trends Microbiol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Profiling of HIV-1 elite neutralizer cohort reveals a CD4bs bnAb for HIV-1 prevention and therapy.
Lutz Gieselmann, Andrew T DeLaitsch, Malena Rohde, Henning Gruell, Christoph Kreer, Penny L Moore

Nat Immunol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Africa COVID-19 legacy-Improved vaccinology for pandemic preparedness.
Penny L Moore, Shabir A Madhi, Glenda Gray

Cell Host Microbe· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contemporary HIV-1 envelope pseudovirus panels for detecting and assessing B cell lineages with broadly neutralizing antibody potential.
Bette Korber, Michael S Seaman, Nonhlanhla N Mkhize, Kelli Greene, Hongmei Gao, Penny L Moore

bioRxiv· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasmodium falciparum Parasitemia Does Not Diminish Neutralizing Antibody Responses After mRNA COVID-19 Booster Vaccination in HIV-infected Adults.
Taraz Samandari, Millicent Achola, Jack N Hutter, Grace Mboya, Walter Otieno, Penny L Moore

J Infect Dis· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Africa is an Essential Partner in the Research and Development of an HIV Vaccine.
Glenda Gray, Carolyn Williamson, Linda-Gail Bekker, Brodie Daniels, Werner Smidt, Penny Moore

Curr HIV Res· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutralizing and binding antibodies are a correlate of risk of COVID-19 in the CoVPN 3008 study in people with HIV.
Nonhlanhla N Mkhize, Bo Zhang, Caroline Brackett, Peter James Elyanu, Asa Tapley, Penny L Moore

Nat Commun· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
VRC01 Selects Rare HIV Escape Mutations After Acquisition in Antibody-Mediated Prevention Trials.
Carolyn Williamson, Lyle Curry, Nonhlanhla N Mkhize, Elena E Giorgi, Craig A Magaret, Penny L Moore

bioRxiv· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutralizing antibody responses over time in a demographically and clinically diverse cohort of individuals recovered from SARS-CoV-2 acquisition in Africa: A cohort study.
Nonhlanhla N Mkhize, Shuying Sue Li, Jiani Hu, Samuel T Robinson, Zaheer Hoosain, Penny L Moore

PLOS Glob Public Health· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid loss of activity but not serum concentration in a passive infusion clinical trial of an HIV neutralizing antibody.
Sharana Mahomed, Nonhlanhla N Mkhize, Leonid A Serebryannyy, Tandile Hermanus, Prudence Kgagudi, Penny L Moore

medRxiv· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanistic insights into increased vulnerability to respiratory infections in HIV-Exposed Uninfected Infants.
Cheryl Cohen, Penny Moore

J Infect Dis· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetics of weight-based compared with fixed dosing of CAP256V2LS, a broadly neutralizing antibody for HIV prevention in women.
Sharana Mahomed, Martin Beliveau, Roberto Heredia-Ortiz, Farzana Osman, Marothi Letsoalo, Penny L Moore

J Antimicrob Chemother· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Humoral, T cell and immune gene expression responses to SARS-CoV-2 vaccination in a small group of children with previous MIS-C.
Timothy F Spracklen, Jonathan Day, Hamza Van Der Ross, Claire Butters, Ntombi Benede, Penny L Moore

Vaccine· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 vaccines elicit differential Fc effector functions.
Nelia P Manamela, Boitumelo M Motsoeneng, Holly Spencer, Tandile Hermanus, Nonkululeko Mzindle, Penny L Moore

iScience· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Profiling a large HIV-1 elite neutralizer cohort reveals remarkable CD4bs bNAb for HIV-1 prevention and therapy.
Lutz Gieselmann, Andrew T DeLaitsch, Malena Rohde, Henning Gruell, Christoph Kreer, Penny L Moore

bioRxiv· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of the broadly neutralizing antibody VRC01 on HIV breakthrough virus populations in antibody-mediated prevention trials.
Carolyn Williamson, Chivonne Moodley, Craig A Magaret, Elena E Giorgi, Morgane Rolland, Penny L Moore

bioRxiv· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hybrid Immunity in a Mozambican Cohort After 1 or 2 Doses of the BBIBP-CorV Vaccine.
Raquel Matavele Chissumba, Gaurav Kwatra, Patrícia Ramgi, Maria Enosse, Adérito Sigaúque, Penny Moore

Clin Infect Dis· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRAVE: a highly accurate method for predicting HIV-1 antibody resistance using large language models for proteins.
Mohammed El Anbari, Tatsiana Bylund, Sijy O'Dell, Emily Tourtellott, Krisha McKee, Penny L Moore

bioRxiv· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Broadly neutralizing antibodies, nonneutralizing antibodies and broadly effector antibodies to prevent HIV transmission?
Philippe Van de Perre, Penny L Moore, Nicolas Nagot, Lucio Gama, Jean-Pierre Moles

AIDS· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinct region-specific neutralization profiles of contemporary HIV-1 clade C against best-in-class broadly neutralizing antibodies.
Jyoti Sutar, Priyanka Jayal, Ranajoy Mullick, Sangeeta Chaudhary, Prajakta Kamble, Penny L Moore

J Virol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinct neutralization sensitivity between adult and infant transmitted/founder HIV-1 subtype C viruses to broadly neutralizing monoclonal antibodies.
Bongiwe Ndlovu, Kamini Gounder, Nelisiwe Zikhali, Lanish Singh, Ntokozo Ntshangase, Penny L Moore

PLoS Pathog· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutralizing Antibody Responses After mRNA COVID-19 Booster Vaccination are Unaffected by Parasitemia in a Malaria-Endemic Setting.
Taraz Samandari, Millicent Achola, Jack N Hutter, Grace Mboya, Walter Otieno, Penny L Moore

medRxiv· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis